Drugs / RUCOSOPASEM MANGANESE
RUCOSOPASEM MANGANESE
also known as
GC4711 · Avasopasem manganese dipropionate · BIS-PROPIONATO(GC4419) · GC-4419 DIPROPIONATE · rucosopasem
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT03762031 | Mar 2019 → Mar 2020 | — | Galera Therapeutics, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT03099824 | Oct 2018 → Jan 2020 | — | Galera Therapeutics, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT03194139 | Sep → Dec 2017 | — | Galera Therapeutics, Inc. | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT04476797 | Oct 2020 → Nov 2023 | non-small cell lung carcinoma | Galera Therapeutics, Inc. | Terminated | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT04698915 | May 2021 → Nov 2023 | pancreas disorder | Galera Therapeutics, Inc. | Terminated | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RUCOSOPASEM MANGANESE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650307 ↗ |
| Known as | Avasopasem manganese dipropionate | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650307 ↗ |
| Known as | BIS-PROPIONATO(GC4419) | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650307 ↗ |
| Known as | GC-4419 DIPROPIONATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650307 ↗ |
| Known as | GC4711 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04476797 ↗ |
| Known as | rucosopasem | “Rucosopasem, an investigational selective dismutase mimetic that converts superoxide to hydrogen peroxide” PMID 38264869 ↗ Jan 2024 |
| Modality | Other / unclassified | “Rucosopasem, an investigational selective dismutase mimetic” PMID 38264869 ↗ Jan 2024 |
| Route | Oral | “when given as an oral capsule” NCT03099824 ↗ |